|
1
|
Garg S, Garg M, Prabhakar N, Malhotra P
and Agarwal R: Unraveling the mystery of Covid-19 cytokine storm:
From skin to organ systems. Dermatol Ther.
33(e13859)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Carod-Artal FJ and García-Moncó JC:
Epidemiology, pathophysiology, and classification of the
neurological symptoms of post-COVID-19 syndrome. Neurol Perspect.
1:S5–S15. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rocha KO, Zanuncio VV, de Freitas BAC and
Lima LM: ‘COVID toes’: A meta-analysis of case and observational
studies on clinical, histopathological, and laboratory findings.
Pediatr Dermatol. 38:1143–1149. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Goetzl EJ and Kapogiannis D: Long-COVID:
Phase 2 of the COVID-19 pandemic. Am J Med. 135:1277–1279.
2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sykes DL, Holdsworth L, Jawad N,
Gunasekera P, Morice AH and Crooks MG: Post-COVID-19 symptom
burden: What is long-COVID and how should we manage It? Lung.
199:113–119. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Castanares-Zapatero D, Chalon P, Kohn L,
Dauvrin M, Detollenaere J, Maertens de Noordhout C, Primus-de Jong
C, Cleemput I and Van den Heede K: Pathophysiology and mechanism of
long COVID: A comprehensive review. Ann Med. 54:1473–1487.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Raveendran AV, Jayadevan R and Sashidharan
S: Long COVID: An overview. Diabetes Metab Syndr. 15:869–875.
2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fernández-de-Las-Peñas C, Palacios-Ceña D,
Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G and
Navarro-Santana M: Prevalence of post-COVID-19 symptoms in
hospitalized and non-hospitalized COVID-19 survivors: A systematic
review and meta-analysis. Eur J Intern Med. 92:55–70.
2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lippi G, Sanchis-Gomar F and Henry BM:
COVID-19 and its long-term sequelae: What do we know in 2023? Pol
Arch Intern Med. 133(16402)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sk Abd Razak R, Ismail A, Abdul Aziz AF,
Suddin LS, Azzeri A and Sha'ari NI: Post-COVID syndrome prevalence:
A systematic review and meta-analysis. BMC Public Health.
24(1785)2024.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kabeerdass N, Thangaswamy S,
Mohanasrinivasan V, Rajasekaran C, Sundaram S, Nooruddin T and
Mathanmohun M: Green synthesis-mediated nanoparticles and their
curative character against post COVID-19 skin diseases. Curr
Pharmacol Rep. 8:409–417. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yuen S: Dermatology services: The new
normal post COVID-19. Skin Health Dis. 1(e30)2021.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
de Masson A, Bouaziz JD, Sulimovic L,
Cassius C, Jachiet M, Ionescu MA, Rybojad M, Bagot M and Duong TA:
SNDV (French National Union of Dermatologists-Venereologists).
Chilblains is a common cutaneous finding during the COVID-19
pandemic: A retrospective nationwide study from France. J Am Acad
Dermatol. 83:667–670. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Aldahish A, Vasudevan R, Salem H,
Alqahtani A, AlQasim S, Alqhatani A, Al Shahrani M, Al Mohsen L,
Hajla M, Calina D and Sharifi-Rad J: Telogen effluvium and
COVID-19: A cross-sectional study. Eur Rev Med Pharmacol Sci.
27:7823–7830. 2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zou H and Daveluy S: Toxic epidermal
necrolysis and Stevens-Johnson syndrome after COVID-19 infection
and vaccination. Australas J Dermatol. 64:e1–e10. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tay MZ, Poh CM, Rénia L, MacAry PA and Ng
LFP: The trinity of COVID-19: Immunity, inflammation and
intervention. Nat Rev Immunol. 20:363–374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Greenhalgh T, Knight M, A'Court C, Buxton
M and Husain L: Management of post-acute covid-19 in primary care.
BMJ. 370(m3026)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Menges D, Ballouz T, Anagnostopoulos A,
Aschmann HE, Domenghino A, Fehr JS and Puhan MA: Burden of
post-COVID-19 syndrome and implications for healthcare service
planning: A population-based cohort study. PLoS One.
16(e0254523)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Peghin M, Palese A, Venturini M, De
Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini
A, Fabris M, et al: Post-COVID-19 symptoms 6 months after acute
infection among hospitalized and non-hospitalized patients. Clin
Microbiol Infect. 27:1507–1513. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Peter RS, Nieters A, Kräusslich HG,
Brockmann SO, Göpel S, Kindle G, Merle U, Steinacker JM,
Rothenbacher D and Kern WV: EPILOC Phase 1 Study Group. Post-acute
sequelae of covid-19 six to 12 months after infection: population
based study. BMJ. 379(e071050)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Popa MV, Bogdan Goroftei ER, Gutu C,
Duceac M, Marcu C, Popescu R, Popescu R, Druguș D and Duceac LD:
Observational study of post-COVID-19 syndrome in healthcare workers
infected with sars-COV-2 virus: General and oral cavity
complications. Rom J Oral Rehabil. 15:198–207. 2023.
|
|
22
|
Munblit D, Bobkova P, Spiridonova E,
Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P,
Andreeva M, DunnGalvin A, et al: Incidence and risk factors for
persistent symptoms in adults previously hospitalized for COVID-19.
Clin Exp Allergy. 51:1107–1120. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Subramanian A, Nirantharakumar K, Hughes
S, Myles P, Wiliams T, Gokhale K, Taverner T, Chandan J, Brown K,
Simms-Williams N, et al: Assessment of 115 symptoms for long COVID
(post-COVID-19 condition) and their risk factors in
non-hospitalised individuals: a retrospective matched cohort study
in UK primary care. Res Sq, 2022.
|
|
24
|
Fischer A, Badier N, Zhang L, Elbéji A,
Wilmes P, Oustric P, Benoy C, Ollert M and Fagherazzi G: Long COVID
classification: Findings from a clustering analysis in the
predi-COVID cohort study. Int J Environ Res Public Health.
19(16018)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Leth S, Gunst JD, Mathiasen V, Hansen K,
Søgaard O, Østergaard L, Jensen-Fangel S, Storgaard M and Agergaard
J: Persistent symptoms in patients recovering from COVID-19 in
Denmark. Open Forum Infect Dis. 8(ofab042)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ariza M, Cano N, Segura B, Adan A,
Bargalló N, Caldú X, Campabadal A, Jurado MA, Mataró M, Pueyo R, et
al: COVID-19 severity is related to poor executive function in
people with post-COVID conditions. J Neurol. 270:2392–2408.
2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Moreno-Pérez O, Merino E, Leon-Ramirez JM,
Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R,
Ruiz-Torregrosa P, Galan I, et al: Post-acute COVID-19 syndrome.
Incidence and risk factors: A Mediterranean cohort study. J Infect.
82:378–383. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dryden M, Mudara C, Vika C, Blumberg L,
Mayet N, Cohen C, Tempia S, Parker A, Nel J, Perumal R, et al:
Post-COVID-19 condition 3 months after hospitalisation with
SARS-CoV-2 in South Africa: A prospective cohort study. Lancet Glob
Health. 10:e1247–e1256. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Šipetić T, Rajković D, Bogavac Stanojević
N, Marinković V, Meštrović A and Rouse MJ: SMART pharmacists
serving the new needs of the post-COVID patients, leaving no-one
behind. Pharmacy (Basel). 11(61)2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Raj SVA, Jacob A, Ambu V, Wilson T and
Renuka R: Post COVID-19 clinical manifestations and its risk
factors among patients in a northern district in Kerala, India. J
Family Med Prim Care. 11:5312–5319. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Funk AL, Kuppermann N, Florin TA, Tancredi
DJ, Xie J, Kim K, Finkelstein Y, Neuman MI, Salvadori MI,
Yock-Corrales A, et al: Post-COVID-19 conditions among children 90
days after SARS-CoV-2 infection. JAMA Netw Open.
5(e2223253)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Asakura T, Kimura T, Kurotori I, Kenichi
K, Hori M, Hosogawa M, Saijo M, Nakanishi K, Iso H and Tamakoshi A:
Case-control study of long COVID, Sapporo, Japan. Emerg Infect Dis.
29:956–966. 2023.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Alkeraye S, Alrashidi A, Alotaibi NS,
Almajli N, Alkhalifah B, Bajunaid N, Alharthi R, AlKaff T and
Alharbi K: The association between hair loss and COVID-19: The
impact of hair loss after COVID-19 infection on the quality of life
among residents in Saudi Arabia. Cureus. 14(e30266)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fernández-de-Las-Peñas C, Martín-Guerrero
JD, Pellicer-Valero ÓJ, Navarro-Pardo E, Gómez-Mayordomo V,
Cuadrado ML, Arias-Navalón JA, Cigarán-Méndez M, Hernández-Barrera
V and Arendt-Nielsen L: Female sex is a risk factor associated with
long-term post-COVID related-symptoms but not with COVID-19
symptoms: The LONG-COVID-EXP-CM multicenter study. J Clin Med.
11:413–423. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jung YH, Ha EH, Choe KW, Lee S, Jo DH and
Lee WJ: Persistent symptoms after acute COVID-19 infection in
omicron era. J Korean Med Sci. 37(e213)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kayaaslan B, Eser F, Kalem AK, Kaya G,
Kaplan B, Kacar D, Hasanoglu I, Coskun B and Guner R: Post-COVID
syndrome: A single-center questionnaire study on 1007 participants
recovered from COVID-19. J Med Virol. 93:6566–6574. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hennig V, Schuh W, Neubert A, Mielenz D,
Jäck HM and Schneider H: Increased risk of chronic fatigue and hair
loss following COVID-19 in individuals with hypohidrotic ectodermal
dysplasia. Orphanet J Rare Dis. 16(373)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Förster C, Colombo MG, Wetzel AJ, Martus P
and Joos S: Persisting symptoms after COVID-19. Dtsch Arztebl Int.
119:167–174. 2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Domènech-Montoliu S, Puig-Barberà J,
Pac-Sa MR, Vidal-Utrillas P, Latorre-Poveda M, Del Rio-González A,
Ferrando-Rubert S, Ferrer-Abad G, Sánchez-Urbano M, Aparisi-Esteve
L, et al: Complications post-COVID-19 and risk factors among
patients after six months of a SARS-CoV-2 infection: A
population-based prospective cohort study. Epidemiologia (Basel).
3:49–67. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Al-Aly Z, Xie Y and Bowe B:
High-dimensional characterization of post-acute sequelae of
COVID-19. Nature. 594:259–264. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Peter RS, Nieters A, Kräusslich HG,
Brockmann SO, Göpel S, Kindle G, Merle U, Steinacker JM,
Rothenbacher D and Kern WV: EPILOC Phase 1 Study Group. Post-acute
sequelae of covid-19 six to 12 months after infection: Population
based study. BMJ. 379(e071050)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Saberian P, Pazooki B, Hasani-Sharamin P,
Garjani K, Ahmadi Hatam Z, Dadashi F and Baratloo A:
Persistent/late-onset complications of COVID-19 in general
population: A cross-sectional study in Tehran, Iran. Int J
Community Based Nurs Midwifery. 10:234–245. 2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rossi A, Magri F, Sernicola A, Michelini
S, Caro G, Muscianese M, Di Fraia M, Chello C, Fortuna MC and
Grieco T: Telogen effluvium after SARS-CoV-2 infection: A series of
cases and possible pathogenetic mechanisms. Skin Appendage Disord.
21:1–5. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Dumont R, Richard V, Lorthe E, Loizeau A,
Pennacchio F, Zaballa ME, Baysson H, Nehme M, Perrin A, L'Huillier
AG, et al: A population-based serological study of post-COVID
syndrome prevalence and risk factors in children and adolescents.
Nat Commun. 13(7086)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
McMahon DE, Gallman AE, Hruza GJ,
Rosenbach M, Lipoff JB, Desai SR, French LE, Lim H, Cyster JG, Fox
LP, et al: Long COVID in the skin: A registry analysis of COVID-19
dermatological duration. Lancet Infect Dis. 21:313–314.
2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Weinstock LB, Brook JB, Walters AS, Goris
A, Afrin LB and Molderings GJ: Mast cell activation symptoms are
prevalent in long-COVID. Int J Infect Dis. 112:217–226.
2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bouwensch C, Hahn V and Boulmé F: Analysis
of 160 nonhospitalized COVID-19 patients with mild to moderate
symptoms from an Austrian general medical practice: From typical
disease pattern to unexpected clinical features. Wien Med
Wochenschr. 172:198–210. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Morris D, Patel K, Rahimi O, Sanyurah O,
Iardino A and Khan N: ANCA vasculitis: A manifestation of
post-Covid-19 syndrome. Respir Med Case Rep.
34(101549)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
De Medeiros VLS, Monteiro-Neto AU, França
DDT, Castelo Branco R, de Miranda Coelho ÉO and Takano DM:
Pemphigus vulgaris after COVID-19: A case of induced autoimmunity.
SN Compr Clin Med. 3:1768–1772. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bekaryssova D, Joshi M, Gupta L,
Yessirkepov M, Gupta P, Zimba O, Gasparyan AY, Ahmed S, Kitas GD
and Agarwal V: Knowledge and perceptions of reactive arthritis
diagnosis and management among healthcare workers during the
COVID-19 pandemic: Online survey. J Korean Med Sci.
37(e355)2022.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Qureshi NK and Bansal SK: Autoimmune
thyroid disease and psoriasis vulgaris after COVID-19 in a male
teenager. Case Rep Pediat. 2021(7584729)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Shimizu H, Matsumoto H, Sasajima T, Suzuki
T, Okubo Y, Fujita Y, Temmoku J, Yoshida S, Asano T, Ohira H, et
al: New-onset dermatomyositis following COVID-19: A case report.
Front Immunol. 13(1002329)2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Gold JE, Okyay RA, Licht WE and Hurley DJ:
Investigation of long COVID prevalence and its relationship to
epstein-barr virus reactivation. Pathogens. 10(763)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gupta A and Singh V: Mucormycosis: ‘The
black fungus’ trampling post-COVID-19 patients. Natl J Maxillofac
Surg. 12:131–132. 2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Saad RH and Mobarak FA: The diversity and
outcome of post-covid mucormycosis: A case report. Int J Surg Case
Rep. 88(106522)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Ahsan T and Rani B: A case of multisystem
inflammatory syndrome post-COVID-19 infection in an adult. Cureus.
12(e11961)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Richter AG, Shields AM, Karim A, Birch D,
Faustini SE, Steadman L, Ward K, Plant T, Reynolds G, Veenith T, et
al: Establishing the prevalence of common tissue-specific
autoantibodies following severe acute respiratory syndrome
coronavirus 2 infection. Clin Exp Immunol. 205:99–105.
2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Fernández-de-Las-Peñas C,
Cancela-Cilleruelo I, Rodríguez-Jiménez J, Gómez-Mayordomo V,
Pellicer-Valero OJ, Martín-Guerrero JD, Hernández-Barrera V,
Arendt-Nielsen L and Torres-Macho J: Associated-onset symptoms and
post-COVID-19 symptoms in hospitalized COVID-19 survivors infected
with wuhan, alpha or delta SARS-CoV-2 variant. Pathogens.
11(725)2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Kim Y, Bitna-Ha Kim SW, Chang HH, Kwon KT,
Bae S and Hwang S: Post-acute COVID-19 syndrome in patients after
12 months from COVID-19 infection in Korea. BMC Infect Dis.
22(93)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Cazzato G, Cascardi E, Colagrande A, Foti
C, Stellacci A, Marrone M, Ingravallo G, Arezzo F, Loizzi V,
Solimando AG, et al: SARS-CoV-2 and skin: New insights and
perspectives. Biomolecules. 12(1212)2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gawaz A and Guenova E: Microvascular skin
manifestations caused by COVID-19. Hamostaseologie. 41:387–396.
2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Pondeljak N and Lugović-Mihić L:
Stress-induced interaction of skin immune cells, hormones, and
neurotransmitters. Clin Ther. 42:757–770. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Mandt N, Geilen CC, Wrobel A, Gelber A,
Kamp H, Orfanos CE and Blume-Peytavi U: Interleukin-4 induces
apoptosis in cultured human follicular keratinocytes, but not in
dermal papilla cells. Eur J Dermatol. 12:432–438. 2002.PubMed/NCBI
|
|
64
|
Genovese G, Moltrasio C, Berti E and
Marzano AV: Skin manifestations associated with COVID-19: Current
knowledge and future perspectives. Dermatology. 237:1–12.
2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mui UN, Haley CT, Vangipuram R and Tyring
SK: Human oncoviruses: Mucocutaneous manifestations, pathogenesis,
therapeutics, and prevention: Hepatitis viruses, human T-cell
leukemia viruses, herpesviruses, and Epstein-Barr virus. J Am Acad
Dermatol. 81:23–41. 2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Deshmukh V, Motwani R, Kumar A, Kumari C
and Raza K: Histopathological observations in COVID-19: A
systematic review. J Clin Pathol. 74:76–83. 2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Najafi MB and Javanmard SH: Post-COVID-19
syndrome mechanisms, prevention and management. Int J Prev Med.
14(59)2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Yong SJ: Long COVID or post-COVID-19
syndrome: Putative pathophysiology, risk factors, and treatments.
Infect Dis (Lond). 53:737–754. 2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Batiha GE, Al-Kuraishy HM, Al-Gareeb AI
and Welson NN: Pathophysiology of post-COVID syndromes: A new
perspective. Virol J. 19(158)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Jimeno-Almazán A, Pallarés JG,
Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz
Martínez BJ, Bernal-Morel E and Courel-Ibáñez J: Post-COVID-19
syndrome and the potential benefits of exercise. Int J Environ Res
Public Health. 18(5329)2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Stoian M, Procopiescu B, Șeitan S and
Scarlat G: Post-COVID-19 syndrome: Insights into a novel
post-infectious systemic disorder. J Med Life. 16:195–202.
2023.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Goren A, Vaño-Galván S, Wambier CG, McCoy
J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold
MH, Kovacevic M, et al: A preliminary observation: Male pattern
hair loss among hospitalized COVID-19 patients in Spain-A potential
clue to the role of androgens in COVID-19 severity. J Cosmet
Dermatol. 19:1545–1547. 2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Nguyen B and Tosti A: Alopecia in patients
with COVID-19: A systematic review and meta-analysis. JAAD Int.
7:67–77. 2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Czech T, Sugihara S and Nishimura Y:
Characteristics of hair loss after COVID-19: A systematic scoping
review. J Cosmet Dermatol. 21:3655–3662. 2022.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Sattur SS and Sattur IS: COVID-19
infection: Impact on hair. Indian J Plast Surg. 54:521–526.
2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Wei KC, Huang MS and Tsung-Hsien C: Dengue
VIPHHFDPC. Front Cell Infect Microbiol. 8(268)2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Gentile P: Hair loss and telogen effluvium
related to COVID-19: The potential implication of adipose-derived
mesenchymal stem cells and platelet-rich plasma as regenerative
strategies. Int J Mol Sci. 23(9116)2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Kinoshita-Ise M, Fukuyama M and Ohyama M:
Recent advances in understanding of the etiopathogenesis,
diagnosis, and management of hair loss diseases. J Clin Med.
12(3259)2023.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Hu R, Mo Q, Xie Y, Xu Y, Chen J, Yang Y,
Zhou H, Tang ZR and Wu WQ: AVMSN: An audio-visual two stream crowd
counting framework under low-quality conditions. IEEE Access.
9(1)2021.
|
|
80
|
Hu R, Tang ZR, Wu EQ, Yang R and Li J:
RDC-SAL: Refine distance compensating with quantum scale-aware
learning for crowd counting and localization. Appl Intell.
52:14336–14348. 2022.
|
